title: Veterans Affairs (VA) Cooperative Study #362.
authors.forename: Marco J  D
authors.initials: MJ
authors.lastname: Tangelder
authors.forename: Alge
authors.initials: A
authors.lastname: Algra
authors.forename: James
authors.initials: J
authors.lastname: Lawson
authors.forename: Hero
authors.initials: H
authors.lastname: van Urk
authors.forename: Bert C
authors.initials: BC
authors.lastname: Eikelboom
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D015331:Cohort Studies; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006787:Hospitals, Veterans; D006801:Humans; D008297:Male; D009426:Netherlands; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000601:surgery*; D011183:Postoperative Complications / Q000517:prevention & control; D011184:Postoperative Period; D018570:Risk Assessment; D015912:Thrombolytic Therapy / Q000379:methods*; D016896:Treatment Outcome; D014481:United States; D014654:Vascular Patency / Q000187:drug effects; D014656:Vascular Surgical Procedures / Q000379:methods; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D014859:Warfarin; D001241:Aspirin